| 0 |
CONTRACEPTION BREAKTHROUGH BLEEDING |
1 |
0.1429 |
| 1 |
PREGNANCY ON ORAL CONTRACEPTIVE |
206 |
0.0785 |
| 2 |
MENSTRUAL HEADACHE |
1 |
0.0714 |
| 3 |
MENSTRUAL CLOTS |
13 |
0.0542 |
| 4 |
POLYMENORRHOEA |
155 |
0.0447 |
| 5 |
INTERMENSTRUAL BLEEDING |
182 |
0.0325 |
| 6 |
ABNORMAL MENSTRUAL CLOTS |
5 |
0.0286 |
| 7 |
HEAVY MENSTRUAL BLEEDING |
245 |
0.0272 |
| 8 |
VULVOVAGINAL ULCERATION |
1 |
0.0204 |
| 9 |
MENSTRUAL DISCOMFORT |
2 |
0.0167 |
| 10 |
NONINFECTIVE OOPHORITIS |
1 |
0.0149 |
| 11 |
NEUROLOGICAL INFECTION |
1 |
0.0101 |
| 12 |
BIOCHEMICAL PREGNANCY |
1 |
0.0093 |
| 13 |
PROGESTERONE INCREASED |
1 |
0.0090 |
| 14 |
OVARIAN RUPTURE |
1 |
0.0085 |
| 15 |
PREMENSTRUAL PAIN |
1 |
0.0076 |
| 16 |
HEPATITIS C RNA POSITIVE |
1 |
0.0058 |
| 17 |
MENOPAUSAL SYMPTOMS |
13 |
0.0056 |
| 18 |
HYPOMENORRHOEA |
15 |
0.0055 |
| 19 |
POLYCYSTIC OVARIAN SYNDROME |
2 |
0.0052 |
| 20 |
PREMENSTRUAL DYSPHORIC DISORDER |
1 |
0.0049 |
| 21 |
LACTATION INSUFFICIENCY |
1 |
0.0048 |
| 22 |
OVULATION PAIN |
1 |
0.0048 |
| 23 |
DYSMENORRHOEA |
52 |
0.0039 |
| 24 |
MENSTRUAL DISORDER |
32 |
0.0039 |
| 25 |
HEPATITIS C ANTIBODY POSITIVE |
1 |
0.0037 |
| 26 |
OLIGOMENORRHOEA |
8 |
0.0037 |
| 27 |
GENITAL BLISTER |
1 |
0.0036 |
| 28 |
DAIRY INTOLERANCE |
1 |
0.0036 |
| 29 |
CAROTID ARTERY THROMBOSIS |
3 |
0.0035 |
| 30 |
MENSTRUATION DELAYED |
32 |
0.0029 |
| 31 |
VULVOVAGINAL DRYNESS |
8 |
0.0025 |
| 32 |
ACNE CYSTIC |
7 |
0.0023 |
| 33 |
HORMONE LEVEL ABNORMAL |
10 |
0.0020 |
| 34 |
MENSTRUATION IRREGULAR |
51 |
0.0019 |
| 35 |
EXCESSIVE CERUMEN PRODUCTION |
1 |
0.0016 |
| 36 |
ADNEXA UTERI PAIN |
2 |
0.0016 |
| 37 |
BREAST PAIN |
16 |
0.0015 |
| 38 |
CYST RUPTURE |
1 |
0.0015 |
| 39 |
NIPPLE PAIN |
3 |
0.0015 |
| 40 |
CENTRAL SEROUS CHORIORETINOPATHY |
1 |
0.0015 |
| 41 |
PREMENSTRUAL SYNDROME |
2 |
0.0015 |
| 42 |
BLOOD OESTROGEN DECREASED |
1 |
0.0014 |
| 43 |
HAEMORRHAGE IN PREGNANCY |
2 |
0.0014 |
| 44 |
VITAMIN B COMPLEX DEFICIENCY |
1 |
0.0013 |
| 45 |
BREAST TENDERNESS |
10 |
0.0013 |
| 46 |
AMENORRHOEA |
23 |
0.0013 |
| 47 |
ECTOPIC PREGNANCY |
4 |
0.0013 |
| 48 |
RUPTURED ECTOPIC PREGNANCY |
1 |
0.0013 |
| 49 |
INJECTION SITE BURNING |
1 |
0.0013 |
| 50 |
MOOD SWINGS |
39 |
0.0012 |
| 51 |
TESTICULAR ATROPHY |
1 |
0.0011 |
| 52 |
HUMAN CHORIONIC GONADOTROPIN INCREASED |
1 |
0.0011 |
| 53 |
LIGAMENT DISORDER |
1 |
0.0011 |
| 54 |
VULVOVAGINAL PAIN |
5 |
0.0010 |
| 55 |
BREAST DISCOMFORT |
1 |
0.0010 |
| 56 |
VAGINAL HAEMORRHAGE |
40 |
0.0009 |
| 57 |
VAGINAL DISCHARGE |
9 |
0.0009 |
| 58 |
MOOD ALTERED |
24 |
0.0009 |
| 59 |
CARBON DIOXIDE DECREASED |
1 |
0.0009 |
| 60 |
LIBIDO DISORDER |
1 |
0.0008 |
| 61 |
ADVERSE DRUG REACTION |
68 |
0.0008 |
| 62 |
PRODUCT EXPIRATION DATE ISSUE |
1 |
0.0007 |
| 63 |
ACNE |
53 |
0.0007 |
| 64 |
ABORTION |
2 |
0.0007 |
| 65 |
NEGATIVE THOUGHTS |
2 |
0.0007 |
| 66 |
SKIN STRIAE |
1 |
0.0007 |
| 67 |
INFERTILITY |
1 |
0.0007 |
| 68 |
EPICONDYLITIS |
1 |
0.0007 |
| 69 |
MEAN CELL VOLUME DECREASED |
1 |
0.0006 |
| 70 |
AFFECT LABILITY |
6 |
0.0006 |
| 71 |
BREAST ENLARGEMENT |
2 |
0.0006 |
| 72 |
CRYING |
21 |
0.0006 |
| 73 |
ALOPECIA AREATA |
1 |
0.0006 |
| 74 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
31 |
0.0006 |
| 75 |
LOSS OF LIBIDO |
5 |
0.0006 |
| 76 |
MEAN CELL HAEMOGLOBIN DECREASED |
1 |
0.0005 |
| 77 |
SEBORRHOEA |
2 |
0.0005 |
| 78 |
PNEUMONIA KLEBSIELLA |
1 |
0.0005 |
| 79 |
MENOMETRORRHAGIA |
1 |
0.0005 |
| 80 |
ANGER |
17 |
0.0005 |
| 81 |
HYPERPHAGIA |
2 |
0.0005 |
| 82 |
LIPIDS INCREASED |
1 |
0.0005 |
| 83 |
PSYCHOTIC SYMPTOM |
1 |
0.0005 |
| 84 |
PHARYNGEAL ERYTHEMA |
1 |
0.0005 |
| 85 |
INCREASED APPETITE |
9 |
0.0005 |
| 86 |
EMOTIONAL DISORDER |
14 |
0.0005 |
| 87 |
BRAIN FOG |
7 |
0.0004 |
| 88 |
BLOOD LOSS ANAEMIA |
1 |
0.0004 |
| 89 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
3 |
0.0004 |
| 90 |
PUSTULE |
1 |
0.0004 |
| 91 |
OVARIAN CYST |
4 |
0.0004 |
| 92 |
VULVOVAGINAL PRURITUS |
2 |
0.0004 |
| 93 |
FOOD CRAVING |
2 |
0.0004 |
| 94 |
DEPRESSED MOOD |
20 |
0.0004 |
| 95 |
ADVERSE REACTION |
5 |
0.0004 |
| 96 |
BREAST SWELLING |
1 |
0.0004 |
| 97 |
RHEUMATOID NODULE |
1 |
0.0004 |
| 98 |
ABDOMINAL DISTENSION |
36 |
0.0003 |
| 99 |
INTENTIONAL PRODUCT USE ISSUE |
28 |
0.0003 |
| 100 |
SKIN INJURY |
1 |
0.0003 |
| 101 |
PRODUCT ADMINISTRATION ERROR |
6 |
0.0003 |
| 102 |
WOUND COMPLICATION |
1 |
0.0003 |
| 103 |
HAIR GROWTH ABNORMAL |
2 |
0.0003 |
| 104 |
WEIGHT FLUCTUATION |
3 |
0.0003 |
| 105 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
1 |
0.0003 |
| 106 |
WEIGHT INCREASED |
63 |
0.0003 |
| 107 |
ABORTION SPONTANEOUS |
11 |
0.0003 |
| 108 |
EXTRA DOSE ADMINISTERED |
11 |
0.0003 |
| 109 |
PRODUCT DOSE OMISSION ISSUE |
79 |
0.0003 |
| 110 |
PANIC DISORDER |
1 |
0.0003 |
| 111 |
CYST |
3 |
0.0002 |
| 112 |
SELF-INJURIOUS IDEATION |
1 |
0.0002 |
| 113 |
MIGRAINE |
22 |
0.0002 |
| 114 |
VULVOVAGINAL DISCOMFORT |
1 |
0.0002 |
| 115 |
IRON DEFICIENCY |
1 |
0.0002 |
| 116 |
MUSCLE SPASMS |
40 |
0.0002 |
| 117 |
DYSPAREUNIA |
1 |
0.0002 |
| 118 |
YELLOW SKIN |
1 |
0.0002 |
| 119 |
FLANK PAIN |
2 |
0.0002 |
| 120 |
ABORTION INDUCED |
2 |
0.0002 |
| 121 |
INTENTIONAL DOSE OMISSION |
6 |
0.0002 |
| 122 |
ENDOMETRIOSIS |
1 |
0.0002 |
| 123 |
STILLBIRTH |
1 |
0.0002 |
| 124 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
6 |
0.0002 |
| 125 |
INFLAMMATORY MARKER INCREASED |
1 |
0.0002 |
| 126 |
DERMATITIS EXFOLIATIVE |
1 |
0.0002 |
| 127 |
IRRITABILITY |
12 |
0.0002 |
| 128 |
HOT FLUSH |
15 |
0.0002 |
| 129 |
PRODUCT USE IN UNAPPROVED INDICATION |
47 |
0.0002 |
| 130 |
BIPOLAR DISORDER |
2 |
0.0002 |
| 131 |
STRESS CARDIOMYOPATHY |
1 |
0.0002 |
| 132 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 133 |
FOETAL GROWTH RESTRICTION |
1 |
0.0002 |
| 134 |
SUICIDAL IDEATION |
15 |
0.0002 |
| 135 |
VULVOVAGINAL BURNING SENSATION |
1 |
0.0002 |
| 136 |
ADVERSE EVENT |
15 |
0.0002 |
| 137 |
MENISCUS INJURY |
1 |
0.0002 |
| 138 |
ABDOMINAL PAIN LOWER |
4 |
0.0002 |
| 139 |
INCOHERENT |
1 |
0.0002 |
| 140 |
TENDON DISORDER |
1 |
0.0002 |
| 141 |
ALOPECIA |
30 |
0.0002 |
| 142 |
APPETITE DISORDER |
1 |
0.0002 |
| 143 |
SKIN REACTION |
2 |
0.0001 |
| 144 |
MENTAL DISORDER |
6 |
0.0001 |
| 145 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 146 |
PSYCHIATRIC SYMPTOM |
1 |
0.0001 |
| 147 |
DEPRESSION |
30 |
0.0001 |
| 148 |
HAEMOLYSIS |
1 |
0.0001 |
| 149 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
1 |
0.0001 |
| 150 |
THERAPEUTIC RESPONSE UNEXPECTED |
5 |
0.0001 |
| 151 |
PALLOR |
3 |
0.0001 |
| 152 |
OVARIAN CANCER |
1 |
0.0001 |
| 153 |
PERSONALITY CHANGE |
1 |
0.0001 |
| 154 |
HEADACHE |
66 |
0.0001 |
| 155 |
THROMBOTIC MICROANGIOPATHY |
1 |
0.0001 |
| 156 |
NAUSEA |
77 |
0.0001 |
| 157 |
TRANSFUSION |
1 |
0.0001 |
| 158 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 159 |
ABDOMINAL PAIN |
21 |
0.0001 |
| 160 |
ANXIETY |
24 |
0.0001 |
| 161 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 162 |
BACTERAEMIA |
1 |
0.0001 |
| 163 |
PRESYNCOPE |
2 |
0.0001 |
| 164 |
ABNORMAL WEIGHT GAIN |
1 |
0.0001 |
| 165 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 166 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 167 |
HYPOPHAGIA |
2 |
0.0001 |
| 168 |
RASH |
34 |
0.0001 |
| 169 |
ABDOMINAL PAIN UPPER |
16 |
0.0001 |
| 170 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
14 |
0.0001 |
| 171 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 172 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 173 |
SINUS CONGESTION |
1 |
0.0001 |
| 174 |
MEDICATION ERROR |
4 |
0.0001 |
| 175 |
HUNGER |
1 |
0.0001 |
| 176 |
WITHDRAWAL SYNDROME |
3 |
0.0001 |
| 177 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 178 |
PULMONARY ARTERIAL HYPERTENSION |
1 |
0.0001 |
| 179 |
GASTROENTERITIS |
1 |
0.0001 |
| 180 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 181 |
FEELING ABNORMAL |
16 |
0.0001 |
| 182 |
GYNAECOMASTIA |
2 |
0.0001 |
| 183 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 184 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
| 185 |
PREMATURE DELIVERY |
1 |
0.0001 |
| 186 |
GASTROOESOPHAGEAL REFLUX DISEASE |
5 |
0.0001 |
| 187 |
SKIN DISORDER |
2 |
0.0001 |
| 188 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
| 189 |
DYSURIA |
2 |
0.0001 |
| 190 |
DIZZINESS |
27 |
0.0001 |
| 191 |
HYPERSENSITIVITY |
10 |
0.0001 |
| 192 |
THINKING ABNORMAL |
1 |
0.0001 |
| 193 |
LETHARGY |
3 |
0.0001 |
| 194 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 195 |
TASTE DISORDER |
1 |
0.0000 |
| 196 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 197 |
MOUTH ULCERATION |
1 |
0.0000 |
| 198 |
RETCHING |
1 |
0.0000 |
| 199 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 200 |
VOMITING |
21 |
0.0000 |
| 201 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 202 |
THROAT IRRITATION |
2 |
0.0000 |
| 203 |
URTICARIA |
7 |
0.0000 |
| 204 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 205 |
FLUID RETENTION |
2 |
0.0000 |
| 206 |
HYPERHIDROSIS |
5 |
0.0000 |
| 207 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 208 |
ECZEMA |
2 |
0.0000 |
| 209 |
SEDATION |
1 |
0.0000 |
| 210 |
JOINT STIFFNESS |
1 |
0.0000 |
| 211 |
ANHEDONIA |
1 |
0.0000 |
| 212 |
FATIGUE |
29 |
0.0000 |
| 213 |
PAIN OF SKIN |
1 |
0.0000 |
| 214 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 215 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 216 |
FEELING COLD |
1 |
0.0000 |
| 217 |
HAEMOPTYSIS |
1 |
0.0000 |
| 218 |
DECREASED APPETITE |
8 |
0.0000 |
| 219 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 220 |
PREMATURE BABY |
1 |
0.0000 |
| 221 |
SUICIDE ATTEMPT |
2 |
0.0000 |
| 222 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 223 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 224 |
MALAISE |
14 |
0.0000 |
| 225 |
HEAD INJURY |
1 |
0.0000 |
| 226 |
DRUG INTERACTION |
5 |
0.0000 |
| 227 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 228 |
LOSS OF CONSCIOUSNESS |
4 |
0.0000 |
| 229 |
HEART RATE INCREASED |
3 |
0.0000 |
| 230 |
FUNGAL INFECTION |
1 |
0.0000 |
| 231 |
ABDOMINAL DISCOMFORT |
5 |
0.0000 |
| 232 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
6 |
0.0000 |
| 233 |
CONDITION AGGRAVATED |
9 |
0.0000 |
| 234 |
DRUG INEFFECTIVE |
39 |
0.0000 |
| 235 |
VISION BLURRED |
4 |
0.0000 |
| 236 |
NIGHTMARE |
1 |
0.0000 |
| 237 |
CONSTIPATION |
6 |
0.0000 |
| 238 |
PANIC ATTACK |
1 |
0.0000 |
| 239 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 240 |
PRODUCT USE ISSUE |
5 |
0.0000 |
| 241 |
COLITIS |
1 |
0.0000 |
| 242 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 243 |
PAIN |
16 |
0.0000 |
| 244 |
BACK PAIN |
6 |
0.0000 |
| 245 |
PALPITATIONS |
3 |
0.0000 |
| 246 |
PARAESTHESIA |
4 |
0.0000 |
| 247 |
THROMBOSIS |
2 |
0.0000 |
| 248 |
POLLAKIURIA |
1 |
0.0000 |
| 249 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 250 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 251 |
SEPTIC SHOCK |
1 |
0.0000 |
| 252 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 253 |
LIVER DISORDER |
1 |
0.0000 |
| 254 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 255 |
INCORRECT DOSE ADMINISTERED |
5 |
0.0000 |
| 256 |
SKIN IRRITATION |
1 |
0.0000 |
| 257 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 258 |
WEIGHT DECREASED |
6 |
0.0000 |
| 259 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 260 |
SWELLING |
2 |
0.0000 |
| 261 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 262 |
CONTUSION |
2 |
0.0000 |
| 263 |
AGGRESSION |
1 |
0.0000 |
| 264 |
SOMNOLENCE |
4 |
0.0000 |
| 265 |
FLUSHING |
2 |
0.0000 |
| 266 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 267 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 268 |
RASH PRURITIC |
1 |
0.0000 |
| 269 |
PRURITUS |
7 |
0.0000 |
| 270 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 271 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 272 |
BLISTER |
1 |
0.0000 |
| 273 |
EYE PAIN |
1 |
0.0000 |
| 274 |
FLATULENCE |
1 |
0.0000 |
| 275 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 276 |
SEIZURE |
2 |
0.0000 |
| 277 |
CHILLS |
2 |
0.0000 |
| 278 |
NASAL CONGESTION |
1 |
0.0000 |
| 279 |
VERTIGO |
1 |
0.0000 |
| 280 |
DISCOMFORT |
1 |
0.0000 |
| 281 |
FEELING HOT |
1 |
0.0000 |
| 282 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 283 |
DIARRHOEA |
10 |
0.0000 |
| 284 |
RHINORRHOEA |
1 |
0.0000 |
| 285 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 286 |
SWELLING FACE |
1 |
0.0000 |
| 287 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 288 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 289 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 290 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 291 |
SLEEP DISORDER |
1 |
0.0000 |
| 292 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 293 |
AGITATION |
1 |
0.0000 |
| 294 |
HYPOAESTHESIA |
2 |
0.0000 |
| 295 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 296 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 297 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 298 |
OFF LABEL USE |
11 |
0.0000 |
| 299 |
DRY MOUTH |
1 |
0.0000 |
| 300 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 301 |
TREMOR |
2 |
0.0000 |
| 302 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 303 |
MYALGIA |
2 |
0.0000 |
| 304 |
PYREXIA |
4 |
0.0000 |
| 305 |
INSOMNIA |
3 |
0.0000 |
| 306 |
TACHYCARDIA |
1 |
0.0000 |
| 307 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 308 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 309 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 310 |
BREAST CANCER |
1 |
0.0000 |
| 311 |
DYSPNOEA |
6 |
0.0000 |
| 312 |
DYSPHAGIA |
1 |
0.0000 |
| 313 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 314 |
ANAEMIA |
2 |
0.0000 |
| 315 |
DYSPEPSIA |
1 |
0.0000 |
| 316 |
SYNCOPE |
1 |
0.0000 |
| 317 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 318 |
ERYTHEMA |
2 |
0.0000 |
| 319 |
ILLNESS |
1 |
0.0000 |
| 320 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 321 |
HAEMORRHAGE |
1 |
0.0000 |
| 322 |
SEPSIS |
1 |
0.0000 |
| 323 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 324 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 325 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 326 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 327 |
DEHYDRATION |
1 |
0.0000 |
| 328 |
DRY SKIN |
1 |
0.0000 |
| 329 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 330 |
ARTHRALGIA |
3 |
0.0000 |
| 331 |
INFECTION |
1 |
0.0000 |
| 332 |
HOSPITALISATION |
1 |
0.0000 |
| 333 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 334 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 335 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 336 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 337 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 338 |
CHEST PAIN |
1 |
0.0000 |
| 339 |
ASTHENIA |
2 |
0.0000 |
| 340 |
HYPERTENSION |
1 |
0.0000 |
| 341 |
OVERDOSE |
1 |
0.0000 |
| 342 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 343 |
FALL |
1 |
0.0000 |
| 344 |
DEATH |
1 |
0.0000 |